vs
Side-by-side financial comparison of BayCom Corp (BCML) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $25.9M, roughly 1.2× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs -32.1%, a 58.6% gap on every dollar of revenue. On growth, BayCom Corp posted the faster year-over-year revenue change (9.4% vs -4.5%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $25.0K). Over the past eight quarters, BayCom Corp's revenue compounded faster (2.9% CAGR vs -0.1%).
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
BCML vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $25.9M | $31.1M |
| Net Profit | $6.9M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 36.6% | -9.9% |
| Net Margin | 26.5% | -32.1% |
| Revenue YoY | 9.4% | -4.5% |
| Net Profit YoY | 12.1% | -52.0% |
| EPS (diluted) | $0.63 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.9M | — | ||
| Q3 25 | $25.7M | $31.1M | ||
| Q2 25 | $24.7M | — | ||
| Q1 25 | $24.3M | $35.2M | ||
| Q4 24 | $23.7M | $32.6M | ||
| Q3 24 | $25.6M | $24.7M | ||
| Q2 24 | $23.8M | — | ||
| Q1 24 | $24.5M | $35.7M |
| Q4 25 | $6.9M | — | ||
| Q3 25 | $5.0M | $-10.0M | ||
| Q2 25 | $6.4M | — | ||
| Q1 25 | $5.7M | $-14.8M | ||
| Q4 24 | $6.1M | $-6.6M | ||
| Q3 24 | $6.0M | $-16.2M | ||
| Q2 24 | $5.6M | — | ||
| Q1 24 | $5.9M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 36.6% | — | ||
| Q3 25 | 26.3% | -9.9% | ||
| Q2 25 | 35.3% | — | ||
| Q1 25 | 31.6% | -25.7% | ||
| Q4 24 | 34.2% | -6.0% | ||
| Q3 24 | 32.4% | -46.9% | ||
| Q2 24 | 31.9% | — | ||
| Q1 24 | 33.3% | -2.5% |
| Q4 25 | 26.5% | — | ||
| Q3 25 | 19.5% | -32.1% | ||
| Q2 25 | 25.8% | — | ||
| Q1 25 | 23.4% | -42.0% | ||
| Q4 24 | 25.9% | -20.2% | ||
| Q3 24 | 23.5% | -65.7% | ||
| Q2 24 | 23.6% | — | ||
| Q1 24 | 24.0% | 43.8% |
| Q4 25 | $0.63 | — | ||
| Q3 25 | $0.46 | $-0.29 | ||
| Q2 25 | $0.58 | — | ||
| Q1 25 | $0.51 | $-0.47 | ||
| Q4 24 | $0.55 | $-0.25 | ||
| Q3 24 | $0.54 | $-0.53 | ||
| Q2 24 | $0.50 | — | ||
| Q1 24 | $0.51 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $338.6M | $-10.5M |
| Total Assets | $2.6B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $338.6M | — | ||
| Q3 25 | $334.3M | $-10.5M | ||
| Q2 25 | $330.6M | — | ||
| Q1 25 | $329.3M | $2.2M | ||
| Q4 24 | $324.4M | $15.4M | ||
| Q3 24 | $321.7M | $-3.9M | ||
| Q2 24 | $315.3M | — | ||
| Q1 24 | $314.2M | $17.7M |
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | $235.2M | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | $237.7M | ||
| Q4 24 | $2.7B | $255.4M | ||
| Q3 24 | $2.6B | $246.8M | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.6B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $1.8M |
| Free Cash FlowOCF − Capex | $30.1M | $25.0K |
| FCF MarginFCF / Revenue | 116.2% | 0.1% |
| Capex IntensityCapex / Revenue | 6.7% | 5.6% |
| Cash ConversionOCF / Net Profit | 4.64× | — |
| TTM Free Cash FlowTrailing 4 quarters | $51.1M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.8M | — | ||
| Q3 25 | $7.3M | $1.8M | ||
| Q2 25 | $6.4M | — | ||
| Q1 25 | $9.3M | $1.2M | ||
| Q4 24 | $30.4M | $-6.1M | ||
| Q3 24 | $9.6M | $-613.0K | ||
| Q2 24 | $7.7M | — | ||
| Q1 24 | $5.1M | $-1.4M |
| Q4 25 | $30.1M | — | ||
| Q3 25 | $6.2M | $25.0K | ||
| Q2 25 | $5.6M | — | ||
| Q1 25 | $9.1M | $-4.3M | ||
| Q4 24 | $28.7M | $-8.6M | ||
| Q3 24 | $9.4M | $-4.0M | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $3.9M | $-7.8M |
| Q4 25 | 116.2% | — | ||
| Q3 25 | 24.3% | 0.1% | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 37.6% | -12.1% | ||
| Q4 24 | 121.1% | -26.3% | ||
| Q3 24 | 36.6% | -16.3% | ||
| Q2 24 | 31.2% | — | ||
| Q1 24 | 16.1% | -21.8% |
| Q4 25 | 6.7% | — | ||
| Q3 25 | 4.3% | 5.6% | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 0.6% | 15.5% | ||
| Q4 24 | 7.2% | 7.5% | ||
| Q3 24 | 1.0% | 13.9% | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 4.7% | 17.8% |
| Q4 25 | 4.64× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.86× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCML
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
